IV/IA vs IA thrombolytics for acute stroke

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1354, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of Acute Ischaemic Stroke in the Elderly: Tolerability of Thrombolytics

By Tanne D.   Turgeman D.   Adler Y.  

Drugs, Vol. 61, Iss. 10, 2001-01 ,pp. : 1439-1453

Adis International

Access to resources Recommend Favorite

IV alteplase: cost not a factor in acute stroke

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

IV alteplase: cost not a factor in acute stroke

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 315, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Protective effect of a novel antioxidant non-steroidal anti-inflammatory agent (compound IA) on intestinal viability after acute mesenteric ischemia and reperfusion

By Poussios D.   Andreadou I.   Papalois A.   Rekka E.   Gavalakis N.   Aroni K.   Kourounakis P.N.   Fotiadis C.   Sechas M.N.  

European Journal of Pharmacology, Vol. 465, Iss. 3, 2003-04 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite

Administer IA chemotherapy prior to radiotherapy in astrocytoma

By  

Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite